Loading
Latest filing published 12 May 2026 for 팜젠사이언스, €1.7M. Read the official filing
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
한대희, listed as chief executive, has filed trades across 2 companies (mainly through DART (FSS)), most often in HPSP and 팜젠사이언스. We count 2 filings; the first trade dates from 3 April 2026 and the latest from 11 May 2026.
On the market, this insider has only ever bought: 2 purchases, €1.7M in total. The totals exclude 1 filing filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
On 12 May 2026 came the latest disclosure, an open-market purchase for €1.7M in 팜젠사이언스. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.